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Jelena Perovanovic1*, Jyoti Jaswal1, Nikola Markovic2, Eric Hoffman1
From Epigenetics and Chromatin: Interactions and processes
Boston, MA, USA. 11-13 March 2013
Background
During terminal differentiation of cells, there is typically
a transition of the nuclear envelope from the Lamin B
protein to Lamin A/C proteins. This is commensurate
with exit from the cell cycle, and maintenance of the
transcriptional programs associated with the terminally
differentiated cells. Dominant missense mutations in
Lamin A/C cause a broad spectrum of human genetic
disorders, where specific point mutations are associated
with defects in specific organs or tissues. We have previously presented a model where Lamin A/C mutations
disrupt developmentally appropriate interactions between
chromatin and the nuclear envelope and lead to poor
coordination of E2F cell cycle pathways and terminal differentiation pathways [1]. One of the phenotypes caused
by Lamin A/C mutations is Emery Dreifuss Muscular
Dystrophy (EDMD). An X-linked recessive phenocopy of
EDMD is caused by loss of function of emerin – a binding partner to Lamin A/C at the nuclear envelope. Here,
we tested the hypothesis that emerin plays a role in chromatin remodeling via stabilizing nuclear lamina-heterochromatin interactions necessary for appropriate and
time dependent muscle differentiation.
Material and methods
We used WT and emerin null mouse myogenic stem
cells to study transcriptional and epigenetic changes during in vitro exit from the cell cycle and differentiation to
the myogenic lineage. Specific cell cycle (E2F) and myogenic genes were analyzed by qPCR and ChlP-qPCR to
determine mRNA timing and H3K9me3 enrichment on
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gene promoters. Nuclear lamina-chromatin colocalization was determined and quantified by confocal imaging
and Matlab.

Results
Our results showed that TK1 and other cell cycle genes
are inappropriately persistently expressed in emerin null
cells during differentiation causing delayed exit from cell
cycle. Transcripts marking commitment to the myogenic
lineage (myogenin and Mef5A) showed delayed activation
on both mRNA and protein level. Epigenetic imprints
predicted observed deviations from transcriptional timing
in emerin null cells, with persistent suppressive chromatin state on myog promoter upon myogenic induction
and failure to appropriately establish repressive histone
marks (H3K9me3) on Tk1 promoter (cell cycle). Finally,
we showed that the early cell cycle exit and terminal differentiation of emerin null myoblasts were accompanied
by decreased H3K9me3 staining at the nuclear periphery
(lamin A/C immunostaining).
Conclusions
Myogenic cells lacking emerin exhibit perturbations in
terminal commitment to the myogenic lineage. Our transcriptional, chromatin remodeling and gene promoter
accessibility data show that both exit from cell cycle and
terminal commitment to myogenesis are disrupted due to
inappropriate heterochromatin-nuclear lamina interactions in EMD myogenic cells.
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